Avidity Biosciences, Inc. (RNA)

NASDAQ: RNA · IEX Real-Time Price · USD

38.80

-2.48 (-6.01%)

At close: Jul 2, 2024, 4:00 PM

38.51

-0.29 (-0.75%)

After-hours: Jul 2, 2024, 7:56 PM EDT

Avidity Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	3,711	671	1,209	1,115	958	-	Upgrade
Market Cap Growth	87.18%	-44.51%	8.41%	16.40%	-	-	Upgrade
Enterprise Value	2,804	85	608	721	630	-90	Upgrade
PE Ratio	-	-3.16	-6.95	-9.45	-21.59	-	Upgrade
PS Ratio	341.37	70.15	131.02	119.53	141.10	-	Upgrade
PB Ratio	4.47	1.34	2.09	2.92	3.13	-	Upgrade
P/FCF Ratio	-14.15	-5.44	-8.69	-11.31	-25.06	-	Upgrade
P/OCF Ratio	-14.48	-5.63	-8.87	-11.76	-25.80	-	Upgrade
EV/Sales Ratio	257.93	8.87	65.94	77.28	92.86	-38.66	Upgrade
EV/EBITDA Ratio	-5.05	-0.41	-3.58	-6.18	-14.40	5.27	Upgrade
EV/EBIT Ratio	-4.93	-0.40	-3.50	-6.11	-14.28	5.17	Upgrade
EV/FCF Ratio	-7.84	-0.69	-4.37	-7.31	-16.49	-39.75	Upgrade
Debt / Equity Ratio	0.01	0.02	0.02	0.03	0.00	-0.08	Upgrade
Debt / EBITDA Ratio	-0.04	-0.05	-0.06	-0.10	-0.02	-0.29	Upgrade
Debt / FCF Ratio	-0.06	-0.08	-0.08	-0.12	-0.02	2.19	Upgrade
Quick Ratio	12.22	7.38	11.77	13.68	22.51	9.24	Upgrade
Current Ratio	12.47	7.58	12.00	13.86	22.74	9.35	Upgrade
Asset Turnover	0.02	0.02	0.02	0.03	0.02	0.05	Upgrade
Interest Coverage	-	-	-	-	-211.22	-2.35	Upgrade
Return on Equity (ROE)	-38.00%	-39.70%	-40.80%	-35.60%	-20.00%	46.50%	Upgrade
Return on Assets (ROA)	-33.10%	-35.00%	-36.40%	-32.40%	-15.70%	-49.00%	Upgrade
Return on Capital (ROIC)	-30.38%	-46.14%	-30.39%	-30.03%	-14.41%	28.69%	Upgrade
Earnings Yield	-6.16%	-31.65%	-14.40%	-10.59%	-4.63%	-	Upgrade
FCF Yield	-3.88%	-18.38%	-11.51%	-8.84%	-3.99%	-	Upgrade
Buyback Yield / Dilution	-23.82%	-39.97%	-25.91%	-91.24%	-698.49%	-9.53%	Upgrade
Total Shareholder Return	-23.82%	-39.97%	-25.91%	-91.24%	-698.49%	-9.53%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).